Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares IssuedShort-Term Debt repayments
Ratios

BeOne Medicines (BEIGF) Shares Issued (2016 - 2025)

BeOne Medicines (BEIGF) has disclosed Shares Issued for 10 consecutive years, with $19.2 million as the latest value for Q4 2025.

  • Quarterly Shares Issued rose 118.79% to $19.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $196.3 million through Dec 2025, up 332.59% year-over-year, with the annual reading at $196.3 million for FY2025, 332.59% up from the prior year.
  • Shares Issued for Q4 2025 was $19.2 million at BeOne Medicines, down from $80.5 million in the prior quarter.
  • The five-year high for Shares Issued was $3.4 billion in Q4 2021, with the low at $50000.0 in Q3 2021.
  • Average Shares Issued over 5 years is $188.6 million, with a median of $15.5 million recorded in 2024.
  • The sharpest move saw Shares Issued tumbled 100.0% in 2021, then surged 33310.0% in 2022.
  • Over 5 years, Shares Issued stood at $3.4 billion in 2021, then crashed by 99.67% to $11.3 million in 2022, then tumbled by 70.23% to $3.4 million in 2023, then surged by 161.76% to $8.8 million in 2024, then skyrocketed by 118.79% to $19.2 million in 2025.
  • According to Business Quant data, Shares Issued over the past three periods came in at $19.2 million, $80.5 million, and $33.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.